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Abstract 
We have isolated X&opus lueuis cDNA and genomic clones encoding the neuropeptide Y (NPY) mRNA and gene using a 
probe from the human NPY gene. The longest open reading frame in the cDNA encodes a peptide 76% identical to human 
prepro-NPY and 73% identical to rat prepro-NPY. The putative mature Xenopus NPY (XNPY) peptide is 94% identical to both 
human and rat peptides. A genomic clone containing 422 base pairs of 5’-flanking sequences and the 5’-end of the mRNA was 
also isolated. Primer extension analysis was used to map the transcription initiation site of the Xenopus NPY gene. Comparison 
of the 5’flanking sequences of the Xenopus luevis, human, and rat NPY genes resulted in areas of high conservation, including 
the TATA box and the CT box previously shown to interact with Spl-like proteins. Distribution of the Xenopus NPY message 
was analyzed by Northern analysis and RNAse protection. XNPY transcripts were not detected in whole developing embryo 
RNA, but were detected in adult frog brain RNA. We have also conducted preliminary studies of the XNPY promoter, utilizing 
an XNPY/chloramphenicol acetyl-transferase fusion construct. This study has demonstrated that Xenopus NPY shares a high 
degree of identity to its human and rat counterparts and that this homology extends to the gene, which contains similar 
cis-elements positioned near the transcription start site. 
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1. Introduction 
Neuropeptide Y (NPY) is a 36 amino acid peptide 
which is involved in many processes occurring in both 
the central and peripheral nervous systems. The initial 
isolation of the NPY peptide was from porcine brain 
(Tatemoto, 1982). Subsequently, homologs have been 
isolated from a large number species at both the pep- 
tide and cDNA level. NPY is widely distributed within 
the mammalian nervous system, being one of the most 
abundant neuropeptides known (Mione et al., 1990). It 
is often co-localized with other neurotransmitters, in- 
cluding catecholamines or somatostatin (Mione et al., 
1990; O’Donohue et al., 1985). The actions of NPY are 
diverse, involving complex behavioral patterns and bio- 
chemical activities, along with its fundamental activity 
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as a neurotransmitter (McDonald, 1987). In this study 
we have begun an investigation of neuropeptide Y in 
Xenopus laevis, isolating and characterizing the NPY 
gene and determining the tissue distribution of NPY 
mRNA. 
NPY has been implicated or shown to function in 
several diverse and important systems in mammals, 
including the regulation of feeding and carbohydrate 
metabolism (Stanley et al., 1989; McGregor et al., 
1990; Chua et al., 1991; Brady et al., 19901, LHRH 
release (O’Donohue et al., 19851, and of of several 
aspects of the circulatory system (Mione et al., 1990; 
Kawamura et al., 1989; Waeber et al., 1990). 
The ability of NPY to elicit hormone effects has also 
been extended to non-mammalian systems. Synthetic 
NPY inhibits a-MSH release from the neurointermedi- 
ate lobes of Xenopus laevis (Verburg-Van Kemenade 
et al., 1987), and binds a specific cell type in the 
Xenopus Zaevis pituitary (De Rijk et al., 1991). Re- 
cently, McKay et al. (1992) isolated and sequenced the 
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NPY peptide homolog from R. temporaria. This pep- 
tide only had one amino acid substitution when com- 
pared to human NPY, further validating the results 
obtained with synthetic NPY in Xenopus lae/is. 
Several groups have studied the expression and reg- 
ulation of NPY mRNA in mammalian systems. Expres- 
sion of NPY is highest in the frontal cortex and the 
striatum of the human brain, along with the adrenal 
gland (Higuchi et al., 1988). The mRNA has also been 
detected in a non-neuronal cell type, rat megakary- 
ocytes, but not in human megakaryocytes (Ericsson et 
al., 1987; unpublished results). Several studies have 
documented various ways in which NPY mRNA tran- 
scription is regulated. Induction of seizures have been 
shown to increase the concentration of NPY mRNA in 
certain areas of the brain (Bellman et al., 1991). Insulin 
can effect mRNA levels either positively or negatively 
(Fischer-Colbrie et al., 19881. Studies using rat pheo- 
chromocytoma (PC121 or neuroblastoma (NG18TG-2) 
cell lines indicated that NPY mRNA can be positively 
regulated by the actions of glucocorticoids, CAMP ele- 
vation, and protein kinase C activation, either alone or 
when acting synergistically (Higuchi et al., 1988). Fi- 
nally, in Minth et al. (1986) and Minth and Dixon 
(19901, the isolation of the human gene and a study of 
its promoter region are reported. 
The lack of a detailed and coherent picture of NPY 
action along with its wide distribution make further 
study of this peptide and its gene important. In this 
study we report the isolation of a cDNA homolog of 
NPY in Xenopus laevis. We then isolated genomic 
clones containing the 5’-flanking sequences, mapped 
the transcription start, and studied the distribution of 
the NPY transcript in Xenopus. We have also begun 
preliminary investigations of the Xenopus NPY pro- 
moter. These studies will provide an important basis 
for elucidating the regulatory mechanisms governing 
neuronal gene expression conserved throughout evolu- 
tion. 
2. Materials and methods 
Molecular cloning 
Xenopus laevis NPY clones were isolated from a 
Xenopus laevis brain cDNA library constructed in phage 
Agtll (obtained from Drs. K. Richter and I. Dawid). 
The initial NPY probe was a 418 bp ScaI/SphI frag- 
ment from the human NPY cDNA which was labeled 
by the random primer method (Prime-It, Stratagene; 
La Jolla, CA, USA). The random primer probe was 
then used for low stringency hybridization of the above 
library (Minth et al., 1986). Plaque lifts on nitrocellu- 
lose were prehybridized 4 h at 42°C in hybridization 
buffer (43% formamide, 5 x SSPE (750 mM NaCl, 50 
mM NaH,PO,, 5 mM ethylenediamineteraacetic acid 
[EDTAI), 5 x Denhardt’s (0.1% Ficoll, 0.1% 
polyvinylpyrrolidone, 1 mg/ ml bovine serum albumin 
[BSAI), 10 pug/ml tRNA, 0.1% sodium lauryl sulfate 
[SDS]) followed by addition of the labeled probe at 
500000 cpm/ml for 48 h at 42°C. Filters were washed 
at 42°C twice for 1 h in 2 X SSPE, 0.1% SDS and then 
twice for 1 h in 0.5 X SSPE, 0.1% SDS. 
Genomic clones were subsequently isolated from a 
genomic library prepared from homozygous diploid 
Xenopus Zaevis genomic DNA partially digested with 
SauIIIA and ligated into the phage vector EMBL 4 
(obtained from Z. Jonas and I. Dawid). The genomic 
library was screened using a Xenopus NPY probe 
prepared by labeling the XNPY insert from the plas- 
mid pXNPY-1 by the random primer method as de- 
scribed. Screening was performed as described for the 
phage hgtll library. Several positive plaques from the 
genomic library were analyzed and all represented an 
identical clone. All clones from both cDNA and ge- 
nomic phage screens were removed from the vector 
with EcoRI and subcloned into the EcoRI site of 
plasmid pGEM-7 Zf + (Promega; Madison, WI, USA). 
Plasmid pPCRXGNPY-.9 was prepared using ge- 
nomic clone pXGNPY-.9 and the polymerase chain 
reaction (PCR) essentially as described by the manu- 
facturer (Perkin-Elmer-Cetus; Norwalk, CT, USA). The 
first PCR primer corresponded to the 15 nucleotides 
immediately 5’ to the first exon-intron boundary (posi- 
tion 107 to 126; 5’-ATCCCGGGTACTITGGGTCTG- 
TCGAAGATA) with a SmaI containing linker. The 
second primer was complementary to pGEM-7 Zf + 
(positions 154 to 169 in the sequence from Promega, 
S’AACAGCTATGACCATG). The PCR amplified 
fragment of pXGNPY-.9 was digested with XhoI and 
SmaI, isolated, and subcloned into the XhoI/SmaI 
sites of pGEM-7 Zf + _ 
Plasmid pEUCATXGNPY-.9 was constructed by 
isolating the insert from pPCRXGNPY-.9 by restric- 
tion enzyme digestion with SalI/HindIII. This frag- 
ment was then ligated into similarly digested pEU- 
CAT. Plasmid pEUCAT is a derivative of pEMBL8 
CAT with a strong terminator of transcription (Up- 
stream Mouse Sequence, UMS) upstream of the 
polylinker (Piaggio and DeSimone, 1990). 
Sequencing 
Sequencing of double stranded cDNA and genomic 
subclones was carried out using the dideoxy sequencing 
method and the Sequenase kit (USB; Cleveland, OH, 
USA). Overlapping fragments on both strands of clones 
pXNPY-1, pXNPY-8, pXGNPY-.9 and pPCRXGNPY- 
.9 were sequenced completely. Alignments were per- 
formed utilizing Intelligetics software, release 5.35 (In- 
telliGenetics; Mountain View, CA, USA) and MacVec- 
tor software, release 4.0 (Eastman Kodak; Rochester, 
NY, USA). 
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Northern analysis 
The total RNA was prepared for Northern analysis 
and RNAse protection following the procedure of 
Chomczynski and Sacchi (1987). The total RNA sam- 
ples were isolated from adult tissues and embryos 
reared in the laboratory and staged according to 
Nieuwkoop and Faber (1967). Gels (1.5% agarose, 
1 X TAE (40 mM Tris-acetate, 2 mM EDTA), 3% 
formaldehyde) were loaded with 10 pg of total RNA 
per lane. The RNA was then transferred to Nytran 
membranes (Schleicher and Schuell; Keene, NH, USA) 
and hybridized with random primed probes prepared 
from the cDNA clone pXNPY-1 as described. The 
Nytran membranes on which the RNA was immobi- 
lized were pre-hybridized in 20% formamide, 5 X SSPE, 
5% SDS, 500 pg/pl yeast RNA, and 1 X Denhardt’s 
for 1 h at 65°C. These blots were then hybridized with 
the prehybridization buffer containing 10% dextran 
sulfate and 3 X lo6 cpm/ml [a-32P]ATP-labeled probe 
for 12-24 h at 65°C. Subsequently, two washes were 
done in 2 X SSPE, 1% SDS for 30 min at 65°C fol- 
lowed by two additional washes in 0.2 x SSPE, 1% 
SDS for 30 min at 65°C. 
czynski and Sacchi (1987). The amount of total RNA 
recovered was 165 Kg. An mRNA spin column kit (5 
Prime-3 Prime; Boulder, CO, USA) was then used to 
select for poly (A) + RNA, utilizing an oligo(dT)-cel- 
lulose spin column as described by the manufacturer. 
All of the total brain RNA was applied to the column. 
The oligonucleotide utilized in the primer extension 
analysis was B915 (5’~CTITGGGTCTGTCGAAGAT- 
A), which corresponds to the twenty nucleotides of the 
non-sense strand immediately 5’ to the first exon/ 
intron boundary. This oligonucleotide was 5’ end- 
labeled utilizing [ y- 32P]ATP and T4 polynucleotide 
kinase. The labeled oligonucleotide was purified from 
unincorporated ATP by spin column chromatography 
with Bio-Gel P6 (Bio-Rad; Richmond, CA, USA). 
Oocyte injections 
Ovarian tissue was isolated from adult X. laevis and 
defolliculated in 100 mM NaPO, (pH 7.0), 0.4 mg/ml 
collagenase (Sigma; St. Louis, MO, USA, type 1) for 
2-3 h at room temperature. The defolliculated oocytes 
were washed extensively with OR-2 [82.5 mM NaCl, 2.5 
mM KCl, 1.0 mM CaCl,, 1.0 mM MgCl,, 5.0 mM 
Hepes (pH 7.8)], and stored in OR-2 at 18°C. Stage VI 
oocytes (Dumont, 1972) were selected for injection, 
which was carried out as described in Pfaff et al. (1989) 
and Pfaff and Taylor (1992). The DNA samples were 
injected into germinal vesicles in a volume of 4 nl 
controlled by a picospritzer II (General Valve; Fair- 
field, NJ, USA). The NPY/CAT chimeric gene con- 
struct pEUCATXGNPY-.9 or the reporter construct 
pEUCAT dissolved in water was injected at 0.4 mg/ml. 
After a 24 h incubation at 18°C pools of 20 oocytes 
were selected for primer extension analysis of RNA. 
The hybridization of the labeled oligonucleotide and 
the oocyte and brain RNA was carried out according to 
Ausebel et al. (19891, with some modifications. Each 
RNA sample was ethanol precipitated, then resus- 
pended in 15 ~1 hybridization buffer (0.15 M KCl, 10 
mM Tris, pH 8.5, 1 mM EDTA) containing 500000 
cpm of oligonucleotide B915. The tubes were then 
incubated for 90 min in a 65°C water bath. The tubes 
were next removed and allowed to cool to room tem- 
perature. After cooling, 80 ~1 of the reverse transcrip- 
tase cocktail [lo mM MgCl,, 20 mM Tris, pH 8.5, 10 
mM DTT, 10 mM each dATP, dTTP, dCTP, dGTP 
and 2.5 units avian myoblastosis virus reverse transcrip- 
tase (Promega; Madison, WI, USA)] was added. The 
tubes were then incubated 60 min in a 37°C water bath. 
Next, the reaction mixture was then extracted once 
with phenol, once with phenol-chloroform (1: 1) .and 
once with chloroform. The samples were then ethanol 
precipitated (without additional salt). The pellets were 
resuspended in 1: 1 water, sequencing buffer (90% 
deionized formamide, 20 mM EDTA, 0.03% xylene 
cyan01 and bromophenol blue). Finally, the samples 
were run on a 5% sequencing gel. 
Primer extension analysis 
The pooled, injected oocytes were homogenized by 
vigorous vortexing in 600 ~1 of 1 X SET (0.15 M NaCl, 
5 mM EDTA, 50 mM Tris, pH 7.8, 2% SDS and 0.5 
mg/ml proteinase K). The oocyte mixture was incu- 
bated for 40 min at room temperature. The mixture 
was then extracted twice with phenol, twice with phe- 
nol-chloroform (1: 1) and once with chloroform. The 
RNA was recovered by ethanol precipitation. 
A sequencing ladder was run alongside the primer 
extension products to accurately determine the tran- 
scription start site. This sequencing ladder was made 
using the same labeled B915 oligonucleotide used as a 
primer in the primer extension reactions, with 
pPCRXGNPY-.9 as the template. The sequencing re- 
actions were carried out using the Circumvent thermal 
cycle dideoxy DNA sequencing kit (New England Bio- 
labs; Beverly, MA, USA) as described by the manufac- 
turer. 
3. Results 
The poly (A) + Xenopus brain RNA for primer Isolation of cDNA clones encoding Xenopus NPY 
extension analysis was prepared as follows. Total brain A cDNA library from adult Xenopus brain mRNA 
RNA was prepared from approxiamatly 80 young was screened for the presence of Xenopus laeuis NPY 
Xenopus 1aeui.s frogs according to the method of Chom- clones. Several positive cDNAs were isolated and two 
4 Ll Griffin et al. /molecular and Cellular E~docr~nol~~ f01 (19941 I-10 
were extensively analyzed. pXNPY-1 is 600 nucleotides quence (AATAAA) is located at + 854, and nucleotide 
long, the first nucleotide being 13 base pairs 3’ to the + 876 corresponds to the polyadenylation site. The 
transcription start site. pXNPY-8 is 862 nucleotides in open reading frame encoding the putative XNPY be- 
length, beginning at + 29 and ending with a tract of 15 gins with a methionine codon at + 127 and ends with a 





















ggactttgtcctttctataga..IVS 1 ..ctcgttctattcattcctcttgcagATGCAG 
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GGAAACATGAGGTTGTGGATGTCAGTGCTCACTTTATGTCGCTGATCTGCTTGG 
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TATGGGAAGAGATCATGCCCAGAGACAATGCTTTCAGAG 
































Fig, 1. (A) Schematic representation of the Xenopus NPY sequences used in this study. pXGNPY-.9 was isolated from a genomic library using 
the pXNPY-1 cDNA clone as a hybridization probe (ivs 1 indicates a portion of intron 1). pPCRXGNPY-.9 is a derivative of pXGNPY-.9 
produced by the polymerase chain reaction (Materials and methods). pXNPY-8 and pXNPY-1 were isolated from a Xenopus faeois brain cDNA 
library using probes derived from pXNPY-1 and a human NPY cDNA fragment respectively. The clones were sequenced on both strands. The 
nucleotide defined as the mRNA initiation site (+ 1) was determined using a primer extension assay (Fig. 2). (B) DNA and peptide sequences of 
X. lueuis NPY. combining pXGNPY-.9 and pXNPY-8 (underlined). Sequence corresponding to prepro-XNPY peptide is shown in single letter 
amino acid code above corresponding DNA sequence. 
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partially sequenced and all were contained within 
pXNPY-8. 
Isolation of Xenopus NPY gene and determination of the 
transcription start site 
pXNPY-1 was used as a probe to screen a Xenopus 
genomic DNA library. One clone was isolated and 
sequenced. Comparison of the genomic clone 
(pXGNPY-.9) to the sequence of pXNPY-1 showed 
that it contained 417 nucleotides 5’ to the transcription 
start, the first exon, first intron, and second exon of the 
XNPY gene (Fig. lA,B). 
The transcription start site of the chimeric and 
native XNPY transcripts was determined by primer 
extension analysis. The major start site for the chimeric 
pEUCAT/XNPY promoter construct in oocytes was 
three nucleotides 5’ to the start site detected in Xeno- 
pus brain RNA (Fig. 2). No product was detected in 
oocytes injected with the pEUCAT vector alone. The 
start site detected in the Xenopus brain RNA sample 
was defined as + 1. 
Comparison of Xenopus NPY to the human and rat 
homologs 
The genomic sequences also contained regions of 
similarity, especially in the region immediately up- 
stream of the NPY gene’s transcription start site (Fig. 
4). Similarity of the Xenopus upstream sequences to 
the human (Minth et al., 1986; Minth and Dixon, 1990) 
and rat (Larhammar et al., 1987) sequences was found 
in clusters, the most striking corresponding to a non- 
consensus TATA box (Xenopus - 32, human - 30) 
and an Spl-like cis-element (Xenopus - 56, human 
-571, which were previously mapped in the human 
gene (Minth and Dixon, 1990). Other cis-elements 
identified in the Xenopus NPY gene upstream se- 
quences include an APl-like element (Xenopus - 65, 
human - 70) and a CAAT box (Xenopus - 69, human 
-76) (for review see Mitchell and Tjian, 1989). The 
exon/ intron boundaries analyzed in the Xenopus clone 
all occurred in exactly the same relative position as in 
the mammalian NPY gene. The first of these exon/ 
intron boundaries occurs directly before the first AUG 
(human + 851, such that the first exon is entirely within 
the 5’ untranslated sequence in the mRNA. 
The sequence of the Xenopus NPY cDNA was Further comparisons between Xenopus NPY and 
found to be highly similar to that of human (Minth et human NPY were made by aligning the precursor 
al., 1986) and rat (Larhammar et al., 1987) NPY, peptide encoded by the XNPY open reading frame 
except for several large insertions in the 3’ untrans- with the 97 amino acid NPY precursor from human 
lated region (Fig. 3). The greatest homology in se- and rat. Comparison of these peptides revealed that 
quence was found in the region which codes for the the putative mature hormone from Xenopus is 94% 
prepro-hormone (underlined sequence). Disregarding identical to both human and rat, and the putative 
the insertions in the XNPY cDNA, the maximal align- Xenopus prepro peptide is 75% and 73% identical 
ment for these three cDNA’s results in 61% identity. 
This increases to 74% if only the prepro-hormone 







l c + -3. pEUCATXGNPY-J start 
t 
Fig. 2. Primer extension analysis of Xenopus laeuis poly-A (+ ) RNA and oocyte total RNA injected with pEUCAT and pEUCATXGNPY-.9. An 
w~‘P end-labeled oligonucleotide immediately 5’ to the first exon/intron boundary was utilized as the primer. The autoradiogram was exposed 
2 weeks to visualize the primer extension product in the X. laeuis brain poly A( + ) RNA lane. The remainder of the autoradiogram was exposed 
two days. The sequencing ladder was prepared by thermal cycle sequencing as described (see Materials and methods). The sequence as read from 
the ladder corresponds to the antisense strand; the sequence written to the right is that corresponding to the opposite (sense) strand. 
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when compared to human and rat respectively (Fig. 5). 
Additionally, the mature Xenopus NPY peptide se- 
quence has one conservative amino acid change at 
position 10, glu to asp, from the recently published R. 
temporuria NPY peptide (McKay et al., 1992). 
XNPY mRNA d~~ribu~ion 
Northern blot analysis and RNase protection were 
employed to study the distribution of Xenopus NPY 
mRNA during development and among various tissues 
of adult Xenopus iaeuis. The XNPY message is 940 
nucleotides according to Northern analysis (Fig. 61. 
This corresponds to the size predicted from cDNA 
clones and the 5’ and 3’ boundaries of the transcript, 
along with the addition of 50-100 adenine residues. 
Two higher molecular weight species are also detected 
inte~ittently (3 kb and 6 kb). XNPY message was 
detected in adult Xenop~ brain but was not detected 
in any of the other adult tissues tested (heart, spleen, 
lung) (Fig. 6). Furthermore, XNPY message was not 
detected in total RNA from Xenopus embryos of vari- 
ous stages or the Xenopus cell line AllOI. The results 
of RNase protection experiments essentially parallel 
the Northern analysis, with XNPY RNA detected only 
in adult brain tissue (data not shown). However, the 
possibility exists that XNPY is expressed at a level 
below the limits of detection, especially in Xenopus 
embryos, considering that only a small fraction of the 
whole embryos, which were used to prepare the RNA 
used in these experiments, consists of neural tissue. 
XNPY-CAT chimera expression 
Primer extension analysis was performed on RNA 
isolated from JLenopus oocytes injected with a fusion 
construct containing the E. coli chloramphenicol 
ace~l-transferase gene the expression of which is driven 
Human NPY AcCCCAtCcGclljGctCTCAccCCTCGgagAcgctCGCCCgacAGCAtAGTACttGCcGCcCAGccACgcCcGCgC 16 
I IIll I I III IIII lllll I III/I /III IIIII II II III II I II I 
Rat NPY ATtCCAcCGG TGGagCTCAttCCTCG cAGagGCGCCCAg AGCAgAGTACccGCtGCGCAGagACcaCaGCcC 73 
II II I I I II II I I I II I 
pmw-8 +29 agagCCttgccaatATtgCAgtG~~g~=t~t~~g~~~g~gtggtGg~G~G~gCA~~g~~g~G~g~~~~t~t~G~g~Gt~t=ttcgaC 116 
GCCaGCCAcc 169 
III IIII IIIIIIIIIIlIlI III llIIIIIII IIIIIIIIIIIIIl II IIIIIIIIIIIIII III1 Illll IIII 
GCCCGCCAtGAn?CTAGGTRACRRaCG~~GGGC~~tGGACTGACCCPCGfTCTaTCCCmCTCOTGrr,CTIY;GGcAttC~GCTGAGGg 166 
lIIlllll llllll I lllllll I IIII I III II IIII I II lllll I I llll/Il 
@fNPY- 8 agaCcCaABGATGCagGG_CAtg=Ggt~tGGaTO= 209 
pxNPY-8 
~~~==~~~~-~~=~ CTAC~aGC~~~ 262 
///Ill//Il/IIIIIIl~// ltlllllillllil lllfl lllllllllllllll~llllil II illllllllllllllli lllll 
GTACCCCTCCARGCCGGACACGGGCGA~ACGC~AG~AGA-CA~GCCAGATA~A-~GCt-CGACACTACA~~~-T 259 




III1 IIIIlIIIIIIlIIlIIIIIII llIIllII I 
TCTBATGAGAGRRAGCACAGAAM.TGcCCCCAGAACAaG 352 
II IIIIIIIIlIIIII IIIIIIII IIII IIIIII II IIIIIIII I I IIIIIIIIIIIIIIIIII IIII II II I 
aACaAGACAGAGATA~GgAAGRGAGA~atGCCCaGAGACAa~C~CAGATgTtTggtgGAGAG~GCACAG_CatCCCCCGAtCACG 395 
PTGA?G GGAAAEAgACTECTCTtgGcCTmC CTAtTTl'CagCCCAtATtTCATC 434 
IlIIlIIIIIIII I IIlIIIIIIII IIIllllI lIlllI/l II I IIIIII Ill III1 IIII II lllll 
GCTIClAAGACCCTtCCATGTGGTGATG GGAAATGAaACTTGCTCTCCtGaClTITC CTAg'FTTCccCCCAcATcTCATC 431 
I l/lIllI/I// lllllllllllll I II I I I/II ///I/ I I I 
#NPY- 8 Gt~GACCCTcCCATGTGGn;ATGaaaaccpaaGctcATCttAagTctTtTCCaagtTmCatccataCtTcatagttCtacgacaRat 488 
gtgTaaaAcgagAaTCcaCCcaTCCtACCAAXXA~C agCCACtgtGCTGaATT CtgcAatgtTTT 501 
I I I II II III //I/l////I/I 
tcatCcTst4~CCA9TctgCCtg~CCATG~ C~~~~~~~~~~G~~ 1: .,!,,,A& 500 
I I I/II I I III /Illllll I I I II/I llllll 






@fNPY-8 actacCagagBgBcttgcaagaaagtgccazltat9gaaetcaagtctaaccgcattcctttcggatctaacccgeattCC~tcggactaacc 767 
pXNPY-8 












Fig. 3. Xenopus Iaeuis NPY cDNA sequence, aligned to human and rat cDNA sequences. The portion of the sequence corresponding to 
prepro-NPY in the human cDNA is underlined (87-377). The sequence corresponding to the mature NPY peptide in the human cDNA is 
underlined and overlined (171-278). Capital and small case letters indicate matching and non-matching bases respectively. Gaps were introduced 
to increase the number of aligned bases. 







-69 -65 -56 
“CAAT” API SD-1 
TtctAGTCACagaggcaCAAT--TGACTc------AaGCCCCTCCTGCC-C-A~~~ 
I II/III III III/I I Illlllllllll I I I I I I 
TGGGAGTCACC------CACGTGACTG--CCCGAGGCCCCTCCTGCCGCGgCgAGG~ 
IIIlllIIIIl I l/1llI//l lllllllllllllllllllll I III 
TGGGAGTCACC------CggGCGTGACTGccCCCGAGGCCCCTCCTGCCGCGAC~GGgc 
-33 +I, Xe laevis nowus 
TATA I 
Gaga-AT~GgaaCagcaTGGCtgaG~CttGCTC-A-GgATtgtga 
I lIlI/Il 1 I II Ill Ill/ II 
GCTCCATAAAAG---CCCTGTcGC---G-ACCCGCTCTctGCAcCC 
llllllllllll Ill I II I IIIIlIIII Ill II 
GCTCCATAAAAG---CCCgtTGGC---G-ACCCGCTCTAcGCATCC 
I 
tl, human and rat 
Fig. 4. Comparison of the upstream regions of NPY genes. + 1 is indicated for the Xenopus gene as determined by RNase protection. The 
sequences of the human, rat, and Xenopus genes are compared. The presence of the consensus binding sequences for various frans-acting factors 
(Spl, API, CAAT and TATA) are indicated for the Xenopns upstream sequence. Capital and small case letters indicate matching and 
non-matching bases respectively. Gaps were introduced to increase the number of aligned bases. 
by NPY upstream sequences (-417 to + 126). This 
chimeric construct demonstrated a low level of expres- 
sion (Fig. 2) in Xenopus oocytes. As previously stated, 
the major primer extension product of the XNPY 
promoter construct injected into oocytes is three nu- 
cleotides larger that the primer extension product of 
Xenopus laevis brain RNA. 
4. Discussion 
This study has estabIished that an NPY homolog 
exists in Xenopus laeuis. The extensive similarity be- 
tween the NPY sequence of an amphibian versus that 
found in mammals suggests a basic, conserved function 
for the protein. Amphibians and mammals diverged 
several hundred mihion years ago (Creighton, 1984). 
Since that time, proteins such as cytochrome c and 
hemoglobin-/3 have diverged 17% and 46% respectively 
(Creighton, 1984). The divergence in NPY is only 5.5% 
for the mature peptide and 27% for the prepro-peptide. 
This evidence suggests that along with the conservation 
of sequence, common properties relating to function 
may also be conserved. 
Several studies have ascertained the existence of an 
NPY-like molecule and have used synthetic NPY to 
elicit responses in amphibians. One such study carried 
out by Danger et al. (1985) demonstrated that NPY 
elicited cr-MSH release from the pituitary. Subsequent 
studies using Xenopus further suggested the possibility 
of an NPY-like molecule. Verburg-Van Kemenade et 
al. (19871 showed that NPY immunoreactivi~ is pre- 
Xenopus prepro NPY 
human prepro NPY 1 MLGNKRLGLSGLTIALSLLVCLGaLAERYP~AElWUWYSA 
IIIIII II 1111111111111 III IIIIIIIIIIIIIIIIIIIIIII 
rat prepro NPY 1 MLGNh??mGLcGLTLALSLLVCLGiLA??gYP~~YYSA 
c s 
52 ~I~RYGKRSSPETmlSDvwwREnTENiPRsRfED~~ 
Illllffllllllllllllll II II III II I II II 
52 m ~RYG~SSP~LISDL~ST~PRT~~P~ 
l,,ll”;;;,1,,l,,lll,lllllllllllll IIIIIlII II 
52 LwwINLITRcJ~YGIiRSSPETLISDLLMKESTENaPKTRLEDPsMW 
Fig. 5. Comparison of the Xempzq human and rat prepro-NPY peptides with an alignment of the amino acid sequences. Portions of the 
sequences are identified as follows; signal sequence (italics), mature NPY (bold and underlined), C-terminal peptide (underlined). The deduced 
amino acid sequence for the Xenopus cDNA clones pXNPY-8 (top) and pXNPY-1 (bottom) are shown. 
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sent in the hypothalamus and pituitary of Xenopus 
luevis. They also showed that perfusion of isolated 
neurointermediate lobe tissue with NPY inhibited the 
release of wMSH and other pro-opiomelanocortin de- 
rived peptides, apparently by blocking their secretion. 
De Rijk et al. (1991) subsequently have shown that 
labeled NPY specifically binds to a subset of cells in 
the neurointermediate lobe of Xenupus tfolliculo-stel- 
late cells), and that these cells may be a required 
intermediate for NPY’s action on a-MSH release. The 
results of our study, along with those of McKay et al. 
(19921, further affirms the validity of the previous NPY 
studies in amphibians, and demonstrates that the mes- 
senger RNA for an NPY-like peptide exists in Xenopus 
laevis. 
The distribution of NPY in Xenopus may be even 
more restricted than that seen in rats. The only de- 
tectable message in Xenupus was found in adult brain, 
while rat studies have also detected it in varying 
amounts in heart, ovary, spleen, thymus, kidney, lung, 
bone marrow and adrenal gland, in addition to the 
brain (Ericsson et al., 1987; Higuchi et al., 19881. 
Notably, the only definite non-neuronal expression of 
NPY has been shown in rat megakaryocytes (Ericsson 
et al., 1987). The inability to detect the NPY message 
in non-brain samples in Xenopus may be due to lower 
expression of NPY in peripheral locations and/or a 
more restricted expression in neural subtypes. Devel- 
opmentally, the message for NPY was not detected in 
whole embryos at stages 20 and 45 by Northern blot 
analysis (Fig. 6), or by RNase protection in embryos at 
stages 26,32, and 46 (data not shown). Neural develop- 
ment in Xenopus is well underway in stage 20 embryos. 
Neural folds are in the process of fusing, certain brain 
subdivisions are becoming apparent, and the eyes are 
beginning to protrude (Nieuwkoop and Faber, 1967). 
By stage 4.5, circulation of blood to the gills is begin- 
ning, sense organ structures are becoming organized, 
and motor activity, which begins at stage 24, is well 
established (Nieuwkoop and Faber, 1967). This pattern 
of developmental regulation of NPY is similar to that 
found in rat. In rat, the mRNA for NPY was shown to 
be detectable only in late embryogenesis (Larhammar 
et al., 1987). 
In Northern blots of RNA isolated from Xenopus 
tissues, larger molecular weight RNA’s hybridized to 
the NPY cDNA sequences. The detection of larger 
forms of NPY mRNA is also consistent with results 
from rat (Larhammar et al., 1987). Analysis of these 
anomalous bands in rat indicated that they were not 
due to incomplete processing of the message (Larham- 
mar et al., 1987). Thus, it is currently not apparent 
what these larger RNA species represent. 
The sequencing of the upstream region of the Xeno- 
pus NPY gene allows comparison with previously char- 
acterized c&acting elements present in the human and 
ACTINSIGNAL RELATrvBmS.MuScLE ACTIN 1.4 SIGNAJ., 2.4 6.S 18 a.2 1.0 2.6 





Fig. 6. Northern analysis of the Xenopur NPY transcript. Both blots were hybridized with the pXNPY-1 sequence. Blots were subsequently 
stripped by boiling and reprobed with a Xenopus actin probe and the actin hybridization was quantified by densitometry. (A) Northern blot using 
10 fig (5 and 10 @g from brain) of total Xenopus laeuis RNA from various tissues. (B) Northern blot using 10 pg (5 and 10 pg from brain) of 
total Xenopus lamis RNA from brain, stage 20, and stage 45 Xenopus embryos (Nieuwkoop and Faber, 1967) and a Xerwpus laeu& eel1 line 
(Al 101). 
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rat 5’-flanking sequences. Four well characterized cis- 
elements can be found in the Xenopus NPY promoter 
region reported here. The TATA box (-32) is diver- 
gent from the consensus sequence, TATAA, but 
matches the human and rat NPY promoter sequences 
exactly. Previous work has shown that Xenopus cellular 
extracts contain proteins which can specifically bind an 
Spl-like element (Ben-Hattar et al., 1989). The proxi- 
mal Spl-like region of the Xenopus NPY promoter 
(CCCCTCC, - 50 to - 56 with respect to the transcrip- 
tion initiation site) also is completely conserved in both 
human (-51 to -57) and rat (-51 to -57) NPY 
genes. Studies of the human NPY promoter indicate 
that the proximal Spl-like element c-51) may be im- 
portant for transcription, and that an Spl-like protein 
binds to the -51 element in the human gene (Minth 
and Dixon, 19901. Lastly, the Xenopus NPY gene up- 
stream region contains two other recognizable cis- 
acting elements, a CAAT box (- 69) and an APl-like 
element (TGACTCA) (-65). Proteins which bind 
CAAT-like elements have been detected in Xenopus 
by several groups (Tafuri and Wolffe, 1990; Ben-Hattar 
et al., 1989). Studies have also identified a fos homo- 
logue in Xenopus which binds an APl element and 
activates transcription when heterodimerized with 
murine jun (Kindy and Verma, 1990). These two ele- 
ments have also been identified in the human up- 
stream sequences. The presence of consensus se- 
quences for common transcription factors in the Xeno- 
pus NPY gene upstream sequences, along with the 
similarities existing between these sequences and those 
for the human NPY gene, indicate regions which may 
be important for efficient transcriptional regulation of 
the Xenopus NPY gene. 
This study has identified the Xenopus homolog of 
NPY. These results further validate the applicability of 
previous studies in amphibians, where NPY is seem- 
ingly present and active. Analysis of the peptide en- 
coded further illustrates the conservation of NPY over 
hundreds of millions of years of evolutionary time. This 
conservation indicates that amphibian experimental 
systems may provide a means to further elucidate NPY 
regulation and function. 
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